Bassam Damaj - Net Worth and Insider Trading
Bassam Damaj Net Worth
The estimated net worth of Bassam Damaj is at least $1 Million dollars as of 2024-11-13. Bassam Damaj is the President & CEO, 10% Owner of Innovus Pharmaceuticals Inc and owns about 49,341 shares of Innovus Pharmaceuticals Inc (INNV) stock worth over $1 Million. Details can be seen in Bassam Damaj's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bassam Damaj has not made any transactions after 2013-06-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Bassam Damaj
Bassam Damaj Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bassam Damaj owns 3 companies in total, including Innovus Pharmaceuticals Inc (INNV) , Life On Earth Inc (LFER) , and Seelos Therapeutics Inc (SEEL) .
Click here to see the complete history of Bassam Damaj’s form 4 insider trades.
Insider Ownership Summary of Bassam Damaj
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| INNV | Innovus Pharmaceuticals Inc | 2016-11-16 | director & CHIEF EXECUTIVE OFFICER |
| LFER | Life On Earth Inc | 2014-07-14 | director |
| SEEL | Seelos Therapeutics Inc | 2009-12-14 | director & Chief Executive Officer |
Bassam Damaj Latest Holdings Summary
Bassam Damaj currently owns a total of 1 stock. Bassam Damaj owns 49,341 shares of Innovus Pharmaceuticals Inc (INNV) as of June 12, 2013, with a value of $1 Million.
Latest Holdings of Bassam Damaj
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| INNV | Innovus Pharmaceuticals Inc | 2013-06-12 | 49,341 | 20.82 | 1,027,280 |
Holding Weightings of Bassam Damaj
Bassam Damaj Form 4 Trading Tracker
According to the SEC Form 4 filings, Bassam Damaj has made a total of 0 transactions in Innovus Pharmaceuticals Inc (INNV) over the past 5 years. The most-recent trade in Innovus Pharmaceuticals Inc is the acquisition of 3,970 shares on June 12, 2013, which cost Bassam Damaj around $133,389.
Insider Trading History of Bassam Damaj
- 1
Bassam Damaj Trading Performance
GuruFocus tracks the stock performance after each of Bassam Damaj's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bassam Damaj is 14.79%. GuruFocus also compares Bassam Damaj's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bassam Damaj within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Bassam Damaj's insider trading performs compared to the benchmark.
Performance of Bassam Damaj
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 16.67 | | | | | |
| Relative Return to S&P 500(%) | 12.47 | | | | | |
Bassam Damaj Ownership Network
Ownership Network List of Bassam Damaj
Ownership Network Relation of Bassam Damaj
Bassam Damaj Owned Company Details
What does Innovus Pharmaceuticals Inc do?
Who are the key executives at Innovus Pharmaceuticals Inc?
Bassam Damaj is the director & CHIEF EXECUTIVE OFFICER of Innovus Pharmaceuticals Inc. Other key executives at Innovus Pharmaceuticals Inc include 10 percent owner Armistice Capital, Llc , 10 percent owner Armistice Capital Master Fund Ltd. , and 10 percent owner Steven Boyd .
Innovus Pharmaceuticals Inc (INNV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Innovus Pharmaceuticals Inc (INNV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Innovus Pharmaceuticals Inc (INNV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Innovus Pharmaceuticals Inc (INNV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Innovus Pharmaceuticals Inc Insider Transactions
Bassam Damaj Mailing Address
Above is the net worth, insider trading, and ownership report for Bassam Damaj. You might contact Bassam Damaj via mailing address: C/o Bio-quant, Inc., 6330 Nancy Ridge Drive, Suite 103, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
